CLINICAL_TRIALS
trial_result
· 2024-08-23
Clinical Trial Update: Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis [Phase 1]
Summary
A Phase 1 study evaluating the safety and tolerability of ILV-094 in adults with psoriasis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2024-08-23